[1] [2] Tirzepatide is currently marketed under two primary brand names in the United States: Zepbound for chronic weight management and Mounjaro for type 2 diabetes mellitus
This, of course, falls short characterising the impact in the whole lipid pool
Patients should be instructed to check the beyond-use date before each administration and to properly dispose of any medication that has exceeded this date, even if it appears unchanged
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe renal impairment, active pancreatitis, or unmanaged hypoglycemia
To maintain stable and viable products, Marken conducts routine quality assessments to identify and address any potential issues before they impact patients
Your data is only as good as the compounds you use